Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22452356 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: AZD2281;   Drug: matching placebo

Indicates status has not been verified in more than two years